View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
September 7, 2017updated 06 Dec 2021 9:48am

M&As this week: JHL Biotech, Bio Techne, Metabolon

JHL Biotech has acquired 40% stake in a biomedical company based in Wuhan, China, in a long-term investment pursuit.

JHL Biotech has acquired 40% stake in a biomedical company based in Wuhan, China, in a long-term investment pursuit.

The acquirer company is a biopharmaceutical company based in Taiwan.

US-based life science company Bio Techne has completed the acquisition of Trevigen.

The acquisition was completed in an all-cash transaction and is expected to complement the acquirer company’s product portfolio, as well as be accretive to its adjusted earnings per share in the next financial year.

“US-based life science company Bio Techne has completed the acquisition of Trevigen.”

Also based in the US, the target company is a biotechnology company.

US-based health technology company Metabolon has acquired Metabolomic Discoveries, with the aim of advancing its European presence in metabolomics.

Based in Germany, the target company provides metabolomics and diagnostics services.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology